Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cells.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cells.
Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cells. Prostate. 2023 May; 83(6):534-546.
View in:
PubMed
subject areas
Carcinoma
Epidermal Growth Factor
ErbB Receptors
Erlotinib Hydrochloride
Humans
Ligands
Male
MAP Kinase Signaling System
Phosphorylation
Prostate
Prostatic Neoplasms
authors with profiles
Surya Pratap Singh